Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exponent, Inc.    EXPO

My previous session
Most popular
Delayed Quote. Delayed  - 10/19 10:00:00 pm
48.82 USD   +3.17%
02:08aEXPONENT : American Gas Association Transmission Integrity Managemen..
10/18EXPONENT : 3Q Earnings Snapshot
10/18Exponent Declares Regular Quarterly Dividend
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Exponent : Society of Environmental Toxicology and Chemistry (SETAC) Annual Meeting

share with twitter share with LinkedIn share with facebook
share via e-mail
11/11/2017 | 01:09am CEST
Exponent scientists will be presenting and chairing sessions at the 38th Annual Meeting of the Society of Environmental Toxicology and Chemistry (SETAC) November 12 through November 16, 2017 in Minneapolis, Minnesota.

The theme of the 2017 meeting is, 'Toward a Superior Future: Advancing Science for a Sustainable Environment.' The conference will allow attendees to share and exchange information and ideas to help develop and find solutions to the world's most challenging environmental problems. Over 2,400 scientists from over 40 countries will be in attendance.

SETAC is a non-profit, worldwide professional society whose mission is to support the development of principles and practices for protection, enhancement and management of sustainable environmental quality and ecosystem integrity.

For more information, please see the event website and visit us at Booth #507.

Exponent Platform and Poster Presentations (download our Presentation Handout).
Session Chairs

  • Susan Kane Driscoll: Microplastics in the Aquatic Environment: Fate and Effects
  • Jane Staveley: Pharmaceuticals in the Environment - Potential Environmental and Human Health Impacts

Monday, November 13 - Platform
  • Advancements in Technologies Often Change Previous Norms for Recycling Strategies
    - William Goodfellow, Yoko Masue-Slowey
  • Application of Food Web Models at Superfund Sites: Legal and Political Implications
    - Kirk O'Reilly
  • Addressing White Hat Bias: Lessons from Environmental Litigation
    - Katherine Palmquist
  • Scientific Integrity Issues in Environmental Toxicology
    - Anne Fairbrother and William Goodfellow

Tuesday, November 14 - Platform
  • Toxicity Assessments for NPDES Compliance: Traditional TSD Methods versus the TST Approach
    - William Goodfellow, Susan Paulsen, Katie Marjanovic

Tuesday, November 14 - Posters
  • How Statistical Artifacts Affect the Reliability of Toxicity Thresholds Calculated from Distribution Tails of Field Monitoring Data
    - Roxolana Kashuba, William Goodfellow
  • A Metabolomics Evaluation of Oxygen Containing Compounds Identified In Groundwater from Petroleum Fuel Release Sites
    - Kirk O'Reilly, Sungwoo Ahn

Wednesday, November 15 - Platform
  • PAH Source Identification in Urban Settings: Avoiding the Sin of Oversimplification of Pyrogenic Sources
    - Jaana Pietari, Tarek Saba, and Paul Boehm
  • Application of Receptor Models to Characterize Sources of PAHs in Urban Sediment: Use of Site Specific versus Generic Source Profiles
    - Kirk O'Reilly
Wednesday, November 15 - Posters
  • Use of Read-Across for Testing Estrogen, Androgen, Thyroid, and Steroidogenesis Pathways in Vertebrate Ecological Receptors
    - Margaret McArdle, Jane Staveley, and Elaine Freeman
  • Laboratory, Field, and Analytical Procedures for Using Passive Sampling in the Evaluation of Contaminated Sediments: User's Manual Overview
    - Susan Kane Driscoll
  • Tracking PAH Sources to the Gowanus Canal Superfund Site
    - Tarek Saba, Linda Cook, Natalie Johnson, Jaana Pietari, and Paul Boehm

Thursday, November 16 - Platform
  • Assessing Ecological Risk from the use of a Veterinary Medicinal Product in Cattle: Innovative Approaches for Wildlife Exposure Assessment
    - Josie Nusz and Jane Staveley
  • Environmental Assessment of a Veterinary Drug (Revalor-XR) Containing Trenbolone Acetate and 17β-Estradiol
    - Jane Staveley, Qingli Ma, and Jane Ma

Thursday, November 16 - Posters
  • Groundwater and Surface Water Exposure Assessments of a Veterinary Drug (Revalor-XR) Containing Trenbolone Acetate and 17β-Estradiol
    - Qingli Ma, Jane Staveley, Jane Ma

Exponent Inc. published this content on 12 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 November 2017 00:08:07 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on EXPONENT, INC.
02:08aEXPONENT : American Gas Association Transmission Integrity Management Meeting
10/18EXPONENT : 3Q Earnings Snapshot
10/18EXPONENT INC : Results of Operations and Financial Condition, Regulation FD Disc..
10/18Exponent Declares Regular Quarterly Dividend
10/18Exponent Reports Third Quarter of Fiscal Year 2018 Financial Results
10/17EXPONENT : Biocides Efficacy Training Course
10/14EXPONENT : Industrial Fabrics Association International (IFAI) Expo
10/13EXPONENT : Materials Science & Technology 2018 Conference
10/09EXPONENT : EFSA Residue Definition Guidance Training Workshop
10/09EXPONENT : International Society of Orthopaedic Surgery and Traumatology
More news
News from SeekingAlpha
10/19Exponent +3.5% post Q3 results 
10/18Exponent, Inc. (EXPO) CEO Dr. Catherine Corrigan on Q3 2018 Results - Earning.. 
10/18Exponent declares $0.13 dividend 
10/18Exponent misses by $0.02, beats on revenue 
10/17Notable earnings after Thursday?s close 
Financials ($)
Sales 2018 381 M
EBIT 2018 82,6 M
Net income 2018 71,5 M
Finance 2018 228 M
Yield 2018 1,13%
P/E ratio 2018 36,78
P/E ratio 2019 33,96
EV / Sales 2018 6,07x
EV / Sales 2019 5,49x
Capitalization 2 540 M
Duration : Period :
Exponent, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXPONENT, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 56,8 $
Spread / Average Target 16%
EPS Revisions
Catherine Ford Corrigan President & Chief Executive Officer
Paul R. Johnston Executive Chairman
Richard L. Schlenker CFO, Secretary, Principal Accounting Officer & EVP
Subbaiah V. Malladi Chief Technical Officer & Principal Engineer
John B. Shoven Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EXPONENT, INC.35.19%2 462
WORLDPAY INC7.04%29 667
LG CORP--.--%10 088
BUREAU VERITAS-16.39%9 815